The AstraZeneca crown vaccine is about to be approved in Switzerland. Compared to RNA agents, it is in an important category.
Anke Fossgreen (text), Jürg Candrian (Graphics)
A third crown vaccine is expected to be approved in Switzerland in the coming weeks or days. The first two vaccines, available in Switzerland from December and January, belong to the so-called RNA vaccines. They were manufactured by Biontech / Pfizer and Moderna.